Insightec Ltd. — Cyborg Score 8/10

Strong
Therapeutic ultrasound devices

Strategic Profile

Insightec specializes in non-invasive, precision treatments for movement disorders. The company secured $150M in June 2024, bringing total funding to over $800M, positioning it as a leader in MR-guided focused ultrasound therapy. Strategic partnerships and expanding global reach, including Health Canada approval for the Exablate Prime System in March 2026 and national reimbursement in France for essential tremor treatment in March 2026, support continued market expansion.

Cyborg Score Rationale

Annual revenue reached $100.3 million in 2026, demonstrating strong commercial traction. Employee count was 522 as of March 31, 2026, indicating operational scale. Multiple regulatory approvals and reimbursement wins across geographies underscore market validation and competitive positioning.

Top Insights

  • MR-guided focused ultrasound is an emerging, less-invasive alternative to traditional neurosurgery with strong clinical validation and expanding indications
  • Recent regulatory wins (Health Canada in March 2026, France reimbursement in March 2026) and FDA approvals (Parkinson's in July 2025) accelerate market penetration
  • Strategic partnerships with major medical institutions and pharmaceutical companies (e.g., Charles River collaboration in September 2024) strengthen the ecosystem
  • With $800M+ in total funding and no current public listing plans, Insightec remains well-resourced for R&D, commercial expansion, and potential acquisition targets

Named Competitors

  • HistoSonics — Histotripsy-based ultrasound therapy for cancer
  • Nevro — Neuromodulation devices for chronic pain
  • CVRx — Neuromodulation for cardiovascular conditions

Recent Developments

  • (March 2026) Health Canada approved Insightec's Exablate Prime System
  • (March 2026) Insightec announced national reimbursement in France for essential tremor treatment
  • (December 2025) Insightec spun out Lotus Neuro for brain drug delivery innovation
  • (July 2025) Insightec received FDA approval for Parkinson's Disease treatment

Open the full interactive Insightec Ltd. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →